Medically Reviewed on 11/14/2022

Generic Name: sonidegib

Brand Name: Odomzo

Drug Class: Antineoplastics Hedgehog Pathway Inhibitors

What is sonidegib, and what is it used for?

Sonidegib (odomzo) is a prescription oral medication used to treat a type of skin cancer called basal cell carcinoma that has recurred following surgery or radiation treatment. It also is used for treating basal cell carcinoma that cannot be treated with surgery or radiation.

Sonidegib is an inhibitor of the hedgehog biological signaling pathway, a pathway that promotes the growth of both normal and cancer cells. Sonidegib binds to and inhibits smoothened, a protein involved in hedgehog signaling. Inhibiting smoothened disrupts cell signaling and growth of cancer cells. Sonidegib was approved by the FDA in July, 2015.

What are the side effects of sonidegib?

The most common side effects of sonidegib include

Women taking sonidegib may experience an absence of menstrual periods (amenorrhea). It is not known if amenorrhea is permanent. Women who wish to get pregnant in the future should talk to their doctor for advice.


Skin Cancer Symptoms, Types, Images See Slideshow

What is the dosage for sonidegib?

The recommended dose of sonidegib is 200 mg orally once daily on an empty stomach, at least 1 hour before or 2 hours after a meal. Sonidegib may be taken until the cancer progresses or unacceptable toxicity develops.

What drugs interact with sonidegib?

Sonidegib is broken down by a group of liver enzymes known as cytochrome P4503A (CYP3A). Sonidegib should not be combined with drugs that inhibit the activity of these enzymes because enzyme inhibition may result in high blood levels of sonidegib, leading to increased side effects. Examples of such inhibitors include

Similarly, sonidegib should be combined with drugs that induce (increase the activity) of CYP3A enzymes. Strong CYP3A inducers may decrease blood levels of sonidegib causing treatment failure. Examples of CYP3A inducers include

Is sonidegib safe to take if I'm pregnant or breastfeeding?

Use of sonidegib during pregnancy is not recommended because it may cause death and severe birth defects. Female patients who have been exposed to sonidegib during pregnancy should report their pregnancy to Novartis Pharmaceuticals Corporation by calling 1-888-669-6682.

It is not known whether sonidegib is excreted in breast milk. It should not be used while nursing because there is a potential for serious side effects in the breast fed baby. Additionally, women should not breast feed for at least 20 months after the last dose of sonidegib.

What else should I know about sonidegib?

What preparations of sonidegib are available?

Oral capsules: 200 mg

How should I keep sonidegib stored?

Sonidegib capsules should be stored at room temperature between 15 C and 30 C (59 F and 86 F).


Sonidegib is an oral drug prescribed to treat basal cell carcinoma. Serious side effects such as harm to the fetus if a woman takes Odomzo during pregnancy. The most common side effects of sonidegib include hair loss, weakness, nausea, decreased appetite, vomiting, taste changes, diarrhea, weight loss, stomach pain, headache, pain, muscle pain and spasms, and itching.

Treatment & Diagnosis

Medications & Supplements

Prevention & Wellness

Subscribe to MedicineNet's Cancer Report Newsletter

By clicking "Submit," I agree to the MedicineNet Terms and Conditions and Privacy Policy. I also agree to receive emails from MedicineNet and I understand that I may opt out of MedicineNet subscriptions at any time.

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Medically Reviewed on 11/14/2022
FDA Prescribing Information